Scientists hunt for genetic clues to severe HPV infections
NCT ID NCT05026138
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study is for people aged 3 and older who have severe, recurring HPV-related warts or lesions that don't respond to standard treatments. Researchers want to learn why some people get sicker from HPV than others by studying their genes and immune systems. Participants will provide blood, tissue, and other samples and may be followed for up to 10 years. This is not a treatment study, so there may be no direct benefit, but findings could help develop future therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do young adults know enough about HPV? new survey reveals gaps
- Could a cream after surgery stop cervical cancer in HIV-Positive women?
- Could a malaria drug help fight HPV in women with HIV?
- Can a probiotic gel help women clear HPV and early cervical lesions?
- New HPV test aims to bring screening to more people
- Could 2 HPV vaccine doses be enough for women 27-45? new trial aims to find out.